Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma.
HIV-associated/epidemic Kaposi's sarcoma (EpKS) is an AIDS-defining angio-proliferative malignancy. It can be treated with antiretroviral therapy (ART) alone or with ART plus cytotoxic chemotherapy. ART-treated EpKS can either respond or worsen upon treatment. This study aimed at identifying im...
Main Authors: | Owen Ngalamika, For Yue Tso, Salum Lidenge, Sody Munsaka, Danielle Shea, Charles Wood, John West |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0235865 |
Similar Items
-
Cells of the Innate and Adaptive Immune Systems in Kaposi’s Sarcoma
by: Owen Ngalamika, et al.
Published: (2020-01-01) -
Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence.
by: Owen Ngalamika, et al.
Published: (2021-01-01) -
Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi’s Sarcoma Patients
by: Salum J. Lidenge, et al.
Published: (2020-06-01) -
Prevalence of Kaposi's sarcoma-associated herpesvirus and transfusion-transmissible infections in Tanzanian blood donors
by: Salum J. Lidenge, et al.
Published: (2020-06-01) -
RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.
by: For Yue Tso, et al.
Published: (2018-01-01)